Enveric Biosciences (ENVB) had the highest return between 2014 and 2015 by a US stock, returning 3,748,196.2%.

ASSET	YEARS	% RETURN
Enveric Biosciences (ENVB)	2014-2015	3,748,196.23%
Scinai Immunotherapeutics (SCNI)	2014-2015	791,900%
Scienture (SCNX)	2014-2015	734,114.29%
Skye Bioscience, Inc Common Stock (SKYE)	2014-2015	437,400%
Salarius Pharmaceuticals (SLRX)	2014-2015	388,962.5%
Proficient Auto Logistics, Inc Common Stock (PAL)	2014-2015	72,207.69%
PetVivo (PETV)	2014-2015	52,244.89%
CEA Industries (CEAD)	2014-2015	34,553.47%
Bragg Gaming (BRAG)	2014-2015	2,516.67%
QXO (QXO)	2014-2015	2,007.8%
GreenPro Capital (GRNQ)	2014-2015	1,400%
Patriot National Bancorp (PNBK)	2014-2015	1,287.01%
INVO Bioscience (INVO)	2014-2015	1,196.3%
NAYA Biosciences (NAYA)	2014-2015	1,196.3%
Empire Petroleum (EP)	2014-2015	1,024.38%
FingerMotion (FNGR)	2014-2015	940%
Natural Health Trend (NHTC)	2014-2015	939.81%
Andretti Acquisition Corp II Class A Ordinary Shares (POLE)	2014-2015	896.73%
Panbela Therapeutics (PBLA)	2014-2015	657.58%
Ainos (AIMD)	2014-2015	647.66%
Workhorse (WKHS)	2014-2015	603.91%
Applied Digital (APLD)	2014-2015	580%
Interlink Electronics (LINK)	2014-2015	571.96%
Cyclo Therapeutics (CYTH)	2014-2015	511.79%
Green Brick Partners (GRBK)	2014-2015	510.53%